POSB132 Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients with Acute Heart Failure with Reduced Ejection Fraction: Events Avoided and Cost Savings from the Perspective of Healthcare Payers in the United States

Autor: McEwan, P, Ponikowski, P, Rosano, G, Coats, AJS, Dorigotti, F, O'Sullivan, D, Ramirez de Arellano Serna, A, Jankowska, EA
Zdroj: In Value in Health January 2022 25(1) Supplement:S86-S86
Databáze: ScienceDirect